Penumbra, Inc. (PEN)
324.39
-0.57
(-0.18%)
USD |
NYSE |
Oct 23, 16:00
324.71
+0.32
(+0.10%)
After-Hours: 20:00
Penumbra Enterprise Value : 12.33B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 12.33B |
| October 22, 2026 | 12.35B |
| October 21, 2026 | 12.30B |
| October 20, 2026 | 12.33B |
| October 19, 2026 | 12.25B |
| October 16, 2026 | 12.19B |
| October 15, 2026 | 12.21B |
| October 14, 2026 | 12.16B |
| October 13, 2026 | 12.16B |
| October 12, 2026 | 12.20B |
| October 09, 2026 | 12.13B |
| October 08, 2026 | 12.06B |
| October 07, 2026 | 12.01B |
| October 06, 2026 | 12.04B |
| October 05, 2026 | 12.04B |
| October 02, 2026 | 12.06B |
| October 01, 2026 | 12.08B |
| September 30, 2026 | 12.09B |
| September 29, 2026 | 12.11B |
| September 28, 2026 | 12.13B |
| September 25, 2026 | 12.11B |
| September 24, 2026 | 12.15B |
| September 23, 2026 | 12.14B |
| September 22, 2026 | 12.13B |
| September 21, 2026 | 12.11B |
| Date | Value |
|---|---|
| September 18, 2026 | 12.06B |
| September 17, 2026 | 12.11B |
| September 16, 2026 | 12.10B |
| September 15, 2026 | 12.10B |
| September 14, 2026 | 12.15B |
| September 11, 2026 | 12.07B |
| September 10, 2026 | 12.07B |
| September 09, 2026 | 12.14B |
| September 08, 2026 | 12.13B |
| September 04, 2026 | 12.24B |
| September 03, 2026 | 12.20B |
| September 02, 2026 | 12.27B |
| September 01, 2026 | 12.26B |
| August 31, 2026 | 12.28B |
| August 28, 2026 | 12.22B |
| August 27, 2026 | 12.20B |
| August 26, 2026 | 12.28B |
| August 25, 2026 | 12.33B |
| August 24, 2026 | 12.31B |
| August 21, 2026 | 12.36B |
| August 20, 2026 | 12.31B |
| August 19, 2026 | 12.43B |
| August 18, 2026 | 12.35B |
| August 17, 2026 | 12.44B |
| August 14, 2026 | 12.44B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teleflex, Inc. | 8.333B |
| Boston Scientific Corp. | 78.32B |
| Integra LifeSciences Holdings Corp. | 2.617B |
| Globus Medical, Inc. | 10.45B |
| Abbott Laboratories | 207.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 34.81M |
| Revenue (Quarterly) | 390.05M |
| Total Expenses (Quarterly) | 355.24M |
| EPS Diluted (Quarterly) | 0.8797 |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 8.92% |
| Earnings Yield | 1.26% |
| Operating Earnings Yield | 1.46% |
| Normalized Earnings Yield | 1.255 |